The Murine Sjögren’s Syndrome Disease Activity Index (MuSSDAI), a systemic disease activity score we modelled on the EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI) (Supplementary Table S1), was statistically improved in IFN-K/SWE01 (24.8 ± 2.3 versus 37.8 ± 3.5, p=0.0059) and IFN-K/ISA51-treated (22.1 ± 2.6 versus 36.2 ± 2.2, p=0.0012) mice when compared to their respective controls (Figures 3A, B). This evidence concerns the gene IFNK and Sjogren syndrome.